The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Targeting Glutamine Metabolism for Cancer Treatment
Open accessAbstract
Rapidly proliferating cancer cells require energy and cellular building blocks for their growth and ability to maintain redox balance. Many studies have focused on understanding how cancer cells adapt their nutrient metabolism to meet the high demand of anabolism required for proliferation and maintaining redox balance. Glutamine, the most abundant amino acid in plasma, is a well-known nutrient used by cancer cells to increase proliferation as well as survival under metabolic stress conditions. In this review, we provide an overview of the role of glutamine metabolism in cancer cell survival and growth and highlight the mechanisms by which glutamine metabolism affects cancer cell signaling. Furthermore, we summarize the potential therapeutic approaches of targeting glutamine metabolism for the treatment of numerous types of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941 · cited 2×
“23 tumorigenesis by driving the translation of oncogenic factors, inhibiting autophagy, and enhancing lipid biosynthesis (Zoncu et al., 2011).”
BackgroundRegulation mechanisms and signaling pathways of autophagy
He, C., & Klionsky, D. J. (2009) · Annual Review of Genetics · doi:10.1146/annurev-genet-102808-114910 · Cited by 3,609
Modulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579
Antimicrobial Autophagy: A Conserved Innate Immune Response in Drosophila
Moy, R. H., & Cherry, S. (2013) · Journal of Innate Immunity · doi:10.1159/000350326 · Cited by 3,539
The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1
Sancak, Y., Peterson, T. R., Shaul, Y. D., Lindquist, R. A., Thoreen, C. C., Bar-Peled, L., & Sabatini, D. M. (2008) · Science · doi:10.1126/science.1157535 · Cited by 2,773 · cited 1×
“Glutamine catabolism results in the production of α-KG and stimulates the lysosomal localization of mTORC1 (Sancak et al., 2008; Duran et al., 2012).”
BackgroundDeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
From Krebs to clinic: glutamine metabolism to cancer therapy
Altman, B. J., Stine, Z. E., & Dang, C. V. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.71 · Cited by 2,119
ULK-Atg13-FIP200 Complexes Mediate mTOR Signaling to the Autophagy Machinery
Jung, C. H., Jun, C. B., Ro, S.-H., Kim, Y.-M., Otto, N. M., Cao, J., Kundu, M., & Kim, D.-H. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-12-1249 · Cited by 2,025
Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001 · cited 4×
“Epigallocatechin gallate (EGCG) and R162, an inhibitor of GLUD, as well as aminooxyacetic acid (AOA), a transaminase inhibitor, attenuated tumor growth in preclinical studies by disturbing the anaplerotic use of glutamine in the TCA cycle (Korangath et al., 2015).”
BackgroundInfluentialGlutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Son, J., Lyssiotis, C. A., Ying, H., Wang, X., Hua, S., Ligorio, M., Perera, R. M., Ferrone, C. R., Mullarky, E., Shyh-Chang, N., et al. (2013) · Nature · doi:10.1038/nature12040 · Cited by 1,990
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Metallo, C. M., Gameiro, P. A., Bell, E. L., Mattaini, K. R., Yang, J., Hiller, K., Jewell, C. M., Johnson, Z. R., Irvine, D. J., Guarente, L., et al. (2012) · Nature · doi:10.1038/nature10602 · Cited by 1,791 · cited 3×
“Tracer experiments demonstrated that 1025% of lipogenic acetyl-CoA is derived from glutamine via reductive carboxylation in various types of cancer cells (Metallo et al., 2011).”
BackgroundDeconvoluting the context-dependent role for autophagy in cancer
White, E. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3262 · Cited by 1,704
Serine, glycine and one-carbon units: cancer metabolism in full circle
Locasale, J. W. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3557 · Cited by 1,673
Nutrition Needs of Mammalian Cells in Tissue Culture
Eagle, H. (1955) · Science · doi:10.1126/science.122.3168.501 · Cited by 1,619 · cited 1×
“Therefore, most cancer cells are dependent on glutamine and cannot survive in the absence of exogenous glutamine, which has been termed “glutamine addiction” (Eagle, 1955).”
BackgroundMetabolic pathways promoting cancer cell survival and growth
Boroughs, L. K., & DeBerardinis, R. J. (2015) · Nature Cell Biology · doi:10.1038/ncb3124 · Cited by 1,462
Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer
DeBerardinis, R. J., & Cheng, T. (2010) · Oncogene · doi:10.1038/onc.2009.358 · Cited by 1,365
Sestrin2 is a leucine sensor for the mTORC1 pathway
Wolfson, R. L., Chantranupong, L., Saxton, R. A., Shen, K., Scaria, S. M., Cantor, J. R., & Sabatini, D. M. (2016) · Science · doi:10.1126/science.aab2674 · Cited by 1,306 · cited 1×
“Imported leucine binds to Sestrin2 and disrupts the Sestrin2-GATOR2 interaction, an inhibitor of mTORC1, leading to the translocation of mTORC1 to lysosomes where Rheb-GTPase enhances mTORC1 activity (Saxton et al., 2016; Wolfson et al., 2016).”
BackgroundLubos, E., Loscalzo, J., & Handy, D. E. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3586 · Cited by 1,280
Glutathione Homeostasis and Functions: Potential Targets for Medical Interventions
Lushchak, V. I. (2012) · Journal of Amino Acids · doi:10.1155/2012/736837 · Cited by 1,266 · cited 3×
“GSH can be regenerated from its oxidized form (GSSG), along with the conversion of NADPH to NADP+ (Gorrini et al., 2013).”
BackgroundGlutamine and cancer: cell biology, physiology, and clinical opportunities
Hensley, C. T., Wasti, A. T., & DeBerardinis, R. J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69600 · Cited by 1,262 · cited 1×
“Several studies have shown that glutamine is a major nutrient involved in multiple aspects of cancer metabolism (Hensley et al., 2013).”
BackgroundGlucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells
Le, A., Lane, A. N., Hamaker, M., Bose, S., Gouw, A., Barbi, J., Tsukamoto, T., Rojas, C. J., Slusher, B. S., Zhang, H., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.009 · Cited by 1,095
Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer
Gross, M. I., Demo, S. D., Dennison, J. B., Chen, L., Chernov-Rogan, T., Goyal, B., Janes, J. R., Laidig, G. J., Lewis, E. R., Li, J., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0870 · Cited by 1,068
Ras in Cancer and Developmental Diseases
Fernandez-Medarde, A., & Santos, E. (2011) · Genes & Cancer · doi:10.1177/1947601911411084 · Cited by 897
Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function
Hu, W., Zhang, C., Wu, R., Sun, Y., Levine, A., & Feng, Z. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001006107 · Cited by 862
Glutaminolysis: A Hallmark of Cancer Metabolism
Yang, L., Venneti, S., & Nagrath, D. (2017) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071516-044546 · Cited by 859
Bhaskar, P. T., & Hay, N. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.03.020 · Cited by 798
Uptake and Metabolism of Plasma Glutamine by the Small Intestine
Windmueller, H. G., & Spaeth, A. E. (1974) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)42329-6 · Cited by 790
Nazio, F., Strappazzon, F., Antonioli, M., Bielli, P., Cianfanelli, V., Bordi, M., Gretzmeier, C., Dengjel, J., Piacentini, M., Fimia, G. M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2708 · Cited by 780
Environment impacts the metabolic dependencies of Ras-driven non-small cell lung cancer
Davidson, S. M., Papagiannakopoulos, T., Olenchock, B. A., Heyman, J. E., Keibler, M. A., Luengo, A., Bauer, M. R., Jha, A. K., O’Brien, J. P., Pierce, K. A., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.01.007 · Cited by 737
Glutaminolysis Activates Rag-mTORC1 Signaling
Durán, R. V., Oppliger, W., Robitaille, A. M., Heiserich, L., Skendaj, R., Gottlieb, E., & Hall, M. N. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.05.043 · Cited by 730
Metabolic Reprogramming: the Emerging Concept and Associated Therapeutic Strategies
Yoshida, G. J. (2015) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-015-0221-y · Cited by 716
Suzuki, S., Tanaka, T., Poyurovsky, M. V., Nagano, H., Mayama, T., Ohkubo, S., Lokshin, M., Hosokawa, H., Nakayama, T., Suzuki, Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002459107 · Cited by 705
Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells
Yuneva, M., Zamboni, N., Oefner, P., Sachidanandam, R., & Lazebnik, Y. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200703099 · Cited by 690 · cited 1×
“Similar to KRAS, MYC-overexpressing cancer cells are often addicted to glutamine, such that glutamine deprivation results in MYC-dependent apoptosis (Yuneva et al., 2007).”
BackgroundKRAS: feeding pancreatic cancer proliferation
Bryant, K. L., Mancias, J. D., Kimmelman, A. C., & Der, C. J. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2013.12.004 · Cited by 675
Regulation of Glutaminase Activity and Glutamine Metabolism
Curthoys, N. P., & Watford, M. (1995) · Annual Review of Nutrition · doi:10.1146/annurev.nu.15.070195.001025 · Cited by 664
The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type
Yuneva, M. O., Fan, T. W. M., Allen, T. D., Higashi, R. M., Ferraris, D. V., Tsukamoto, T., Matés, J. M., Alonso, F. J., Wang, C., Seo, Y., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.015 · Cited by 639 · cited 4×
“Epigallocatechin gallate (EGCG) and R162, an inhibitor of GLUD, as well as aminooxyacetic acid (AOA), a transaminase inhibitor, attenuated tumor growth in preclinical studies by disturbing the anaplerotic use of glutamine in the TCA cycle (Korangath et al., 2015).”
BackgroundInfluentialReductive carboxylation supports redox homeostasis during anchorage-independent growth
Jiang, L., Shestov, A. A., Swain, P., Yang, C., Parker, S. J., Wang, Q. A., Terada, L. S., Adams, N. D., McCabe, M. T., Pietrak, B., et al. (2016) · Nature · doi:10.1038/nature17393 · Cited by 582 · cited 5×
“In addition, the IDH1-dependent reductive carboxylation of glutamine generates NADPH, which suppresses mitochondrial ROS in anchorage-independent growth conditions (Jiang et al., 2016).”
BackgroundInfluentialASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer
van Geldermalsen, M., Wang, Q., Nagarajah, R., Marshall, A. D., Thoeng, A., Gao, D., Ritchie, W., Feng, Y., Bailey, C. G., Deng, N., et al. (2016) · Oncogene · doi:10.1038/onc.2015.381 · Cited by 580
Marin-Valencia, I., Yang, C., Mashimo, T., Cho, S., Baek, H., Yang, X.-L., Rajagopalan, K. N., Maddie, M., Vemireddy, V., Zhao, Z., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.05.001 · Cited by 529
Oncogenic K‐Ras decouples glucose and glutamine metabolism to support cancer cell growth
Gaglio, D., Metallo, C. M., Gameiro, P. A., Hiller, K., Danna, L. S., Balestrieri, C., Alberghina, L., Stephanopoulos, G., & Chiaradonna, F. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.56 · Cited by 492
Atg101, a novel mammalian autophagy protein interacting with Atg13
Hosokawa, N., Sasaki, T., Iemura, S.-I., Natsume, T., Hara, T., & Mizushima, N. (2009) · Autophagy · doi:10.4161/auto.5.7.9296 · Cited by 488
Bhutia, Y. D., Babu, E., Ramachandran, S., & Ganapathy, V. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3745 · Cited by 481
Structural basis for leucine sensing by the Sestrin2-mTORC1 pathway
Saxton, R. A., Knockenhauer, K. E., Wolfson, R. L., Chantranupong, L., Pacold, M. E., Wang, T., Schwartz, T. U., & Sabatini, D. M. (2016) · Science · doi:10.1126/science.aad2087 · Cited by 457
Yang, L., Achreja, A., Yeung, T.-L., Mangala, L. S., Jiang, D., Han, C., Baddour, J., Marini, J. C., Ni, J., Nakahara, R., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.10.011 · Cited by 429
Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis
Xiang, Y., Stine, Z. E., Xia, J., Lu, Y., O’Connor, R. S., Altman, B. J., Hsieh, A. L., Gouw, A. M., Thomas, A. G., Gao, P., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci75836 · Cited by 409
Jacque, N., Ronchetti, A. M., Larrue, C., Meunier, G., Birsen, R., Willems, L., Saland, E., Decroocq, J., Maciel, T. T., Lambert, M., et al. (2015) · Blood · doi:10.1182/blood-2015-01-621870 · Cited by 387
ATF4 Regulates MYC-Mediated Neuroblastoma Cell Death upon Glutamine Deprivation
Qing, G., Li, B., Vu, A., Skuli, N., Walton, Z. E., Liu, X., Mayes, P. A., Wise, D. R., Thompson, C. B., Maris, J. M., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.09.021 · Cited by 375
Metabolic reprogramming in cancer: Unraveling the role of glutamine in tumorigenesis
Daye, D., & Wellen, K. E. (2012) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2012.02.002 · Cited by 374
Ammonia Derived from Glutaminolysis Is a Diffusible Regulator of Autophagy
Eng, C. H., Yu, K., Lucas, J., White, E., & Abraham, R. T. (2010) · Science Signaling · doi:10.1126/scisignal.2000911 · Cited by 334
Yang, L., Moss, T., Mangala, L. S., Marini, J., Zhao, H., Wahlig, S., Armaiz‐Pena, G., Jiang, D., Achreja, A., Win, J., et al. (2014) · Molecular Systems Biology · doi:10.1002/msb.20134892 · Cited by 326 · cited 2×
“…is converted to α-ketoglutarate by either glutamate dehydrogenase (GLUD), which releases ammonium, or by aminotransferases, which transfers amino nitrogen from glutamate to produce another amino acid (alanine and aspartate) and α-ketoglutarate, without producing ammonia (Yang et al., 2017).”
BackgroundROS-mediated mechanisms of autophagy stimulation and their relevance in cancer therapy
Dewaele, M., Maes, H., & Agostinis, P. (2010) · Autophagy · doi:10.4161/auto.6.7.12113 · Cited by 306
Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment
Tanaka, K., Sasayama, T., Irino, Y., Takata, K., Nagashima, H., Satoh, N., Kyotani, K., Mizowaki, T., Imahori, T., Ejima, Y., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78239 · Cited by 239
Glutaminase Isoenzymes as Key Regulators in Metabolic and Oxidative Stress Against Cancer
Mates, J. M., Segura, J. A., Martin-Rufian, M., Campos-Sandoval, J. A., Alonso, F. J., & Marquez, J. (2013) · Current Molecular Medicine · doi:10.2174/1566524011313040005 · Cited by 203
Targeting Glutamine Induces Apoptosis: A Cancer Therapy Approach
Chen, L., & Cui, H. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160922830 · Cited by 184
Targeting Glutamine Metabolism in Breast Cancer with Aminooxyacetate
Korangath, P., Teo, W. W., Sadik, H., Han, L., Mori, N., Huijts, C. M., Wildes, F., Bharti, S., Zhang, Z., Santa-Maria, C. A., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1200 · Cited by 182 · cited 1×
“Epigallocatechin gallate (EGCG) and R162, an inhibitor of GLUD, as well as aminooxyacetic acid (AOA), a transaminase inhibitor, attenuated tumor growth in preclinical studies by disturbing the anaplerotic use of glutamine in the TCA cycle (Korangath et al., 2015).”
BackgroundResistance to BRAF inhibitors induces glutamine dependency in melanoma cells
Baenke, F., Chaneton, B., Smith, M., Van Den Broek, N., Hogan, K., Tang, H., Viros, A., Martin, M., Galbraith, L., Girotti, M. R., et al. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2015.08.003 · Cited by 181
Targeting SLC1a5‐mediated glutamine dependence in non‐small cell lung cancer
Hassanein, M., Qian, J., Hoeksema, M. D., Wang, J., Jacobovitz, M., Ji, X., Harris, F. T., Harris, B. K., Boyd, K. L., Chen, H., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29535 · Cited by 166
Gaglio, D., Soldati, C., Vanoni, M., Alberghina, L., & Chiaradonna, F. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004715 · Cited by 164 · cited 2×
“Glutamine-derived amide nitrogen units are added to the growing purine and pyrimidine rings, which can explain the observation that K-RAS-transformed cells exhibit a delayed transit through S phase under low glutamine conditions, due to a reduced supply of DNA building blocks (Gaglio et al., 2009).”
BackgroundRedox control of glutamine utilization in cancer
Alberghina, L., & Gaglio, D. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.513 · Cited by 164
MYC-induced reprogramming of glutamine catabolism supports optimal virus replication
Thai, M., Thaker, S. K., Feng, J., Du, Y., Hu, H., Wu, T., Graeber, T. G., Braas, D., & Christofk, H. R. (2015) · Nature Communications · doi:10.1038/ncomms9873 · Cited by 164
Glutaminase: A Hot Spot For Regulation Of Cancer Cell Metabolism?
Erickson, J. W., & Cerione, R. A. (2010) · Oncotarget · doi:10.18632/oncotarget.208 · Cited by 158
Masson, J., Darmon, M. C., Conjard‐Duplany, A., Chuhma, N., Ropert, N., Thoby‐Brisson, M., Foutz, A. S., Parrot, S., Miller, G. M., Jorisch, R., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.4241-05.2006 · Cited by 143
Vemurafenib resistance reprograms melanoma cells towards glutamine dependence
Hernandez-Davies, J. E., Tran, T. Q., Reid, M. A., Rosales, K. R., Lowman, X. H., Pan, M., Moriceau, G., Yang, Y., Wu, J., Lo, R. S., et al. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0581-2 · Cited by 131
Yu, D., Shi, X., Meng, G., Chen, J., Chen, Y., Jiang, Y., Wei, J., & Ding, Y. (2015) · Oncotarget · doi:10.18632/oncotarget.3196 · Cited by 125
Altered Glutamine Metabolism and Therapeutic Opportunities for Lung Cancer
Mohamed, A., Deng, X., Khuri, F. R., & Owonikoko, T. K. (2013) · Clinical Lung Cancer · doi:10.1016/j.cllc.2013.09.001 · Cited by 121
Xiang, L., Xie, G., Liu, C., Zhou, J., Chen, J., Yu, S., Li, J., Pang, X., Shi, H., & Liang, H. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.08.003 · Cited by 117
Glutamine Addiction In Gliomas
Márquez, J., Alonso, F. J., Matés, J. M., Segura, J. A., Martín‐Rufián, M., & Campos-Sandoval, J. A. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2212-1 · Cited by 115
Zhang, C., Liu, J., Zhao, Y., Yue, X., Zhu, Y., Wang, X., Wu, H., Blanco, F., Li, S., Bhanot, G., et al. (2016) · eLife · doi:10.7554/elife.10727 · Cited by 113
Sanchez, E. L., Carroll, P. A., Thalhofer, A. B., & Lagunoff, M. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005052 · Cited by 108
Li, D., Fu, Z., Chen, R., Zhao, X., Zhou, Y., Zeng, B., Yu, M., Zhou, Q., Lin, Q., Gao, W., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5150 · Cited by 105
Erratum: From Krebs to clinic: glutamine metabolism to cancer therapy
Altman, B. J., Stine, Z. E., & Dang, C. V. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.131 · Cited by 101
GLS2 is transcriptionally regulated by p73 and contributes to neuronal differentiation
Velletri, T., Romeo, F., Tucci, P., Peschiaroli, A., Annicchiarico‐Petruzzelli, M., Niklison-Chirou, M. V., Amelio, I., Knight, R. A., Mak, T. W., Melino, G., et al. (2013) · Cell Cycle · doi:10.4161/cc.26771 · Cited by 99
Byun, J., Choi, Y., Kim, J. H., Jeong, J. Y., Jeon, H., Kim, M. K., Hwang, I., Lee, S.-Y., Lee, Y. M., Lee, I., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.066 · Cited by 88
Self-citationp63 regulates glutaminase 2 expression
Giacobbe, A., Bongiorno‐Borbone, L., Bernassola, F., Terrinoni, A., Markert, E. K., Levine, A. J., Fen, Z., Agostini, M., Zolla, L., Finazzi‐Agrò, A., et al. (2013) · Cell Cycle · doi:10.4161/cc.24478 · Cited by 87
PPARδ Reprograms Glutamine Metabolism in Sorafenib-Resistant HCC
Kim, M. J., Choi, Y., Park, S. Y., Jang, S. Y., Lee, J. Y., Ham, H. J., Kim, B., Jeon, H., Kim, J. H., Kim, J., et al. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0061 · Cited by 82
Self-citationLee, J., Kang, J. J., & Stipanuk, M. H. (2005) · Biochemical Journal · doi:10.1042/bj20051111 · Cited by 74
Epigenetic silencing of glutaminase 2 in human liver and colon cancers
Zhang, J., Wang, C., Chen, M., Cao, J., Zhong, Y., Chen, L., Shen, H., & Xia, D. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-601 · Cited by 67
Glutaminase 2 stabilizes Dicer to repress Snail and metastasis in hepatocellular carcinoma cells
Kuo, T.-C., Chen, C.-K., Hua, K., Yu, P., Lee, W.-J., Chen, M.-W., Jeng, Y., Chien, M., Kuo, K.-T., Hsiao, M., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.10.012 · Cited by 57
Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC
Lee, J.-S., Kang, J. H., Lee, S.-H., Hong, D., Son, J., Hong, K. M., Song, J., & Kim, S.-Y. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.404 · Cited by 56
Szeliga, M., Bogacińska-Karaś, M., Kuzmicz‐Kowalska, K., Rola, R., & Albrecht, J. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22372 · Cited by 40
Cheong, H., Lindsten, T., & Thompson, C. B. (2012) · Autophagy · doi:10.4161/auto.8.1.18078 · Cited by 37
Katt, W. P., Antonyak, M. A., & Cerione, R. A. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500405h · Cited by 33
Cancer metabolism: targeting cancer universality
Kim, S. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0551-5 · Cited by 14
Cited by
Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma
Du, D., Liu, C., Qin, M., Zhang, X., Xi, T., Yuan, S., Hao, H., & Xiong, J. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.09.019 · Cited by 643
Targeting glutamine metabolism as a therapeutic strategy for cancer
Jin, J., Byun, J.-K., Choi, Y.-K., & Park, K.-G. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-00971-9 · Cited by 550
Self-citationAltered metabolism in cancer: insights into energy pathways and therapeutic targets
Tufail, M., Jiang, C.-H., & Li, N. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02119-3 · Cited by 534
The Double-Edge Sword of Autophagy in Cancer: From Tumor Suppression to Pro-tumor Activity
Chavez-Dominguez, R., Perez-Medina, M., Lopez-Gonzalez, J. S., Galicia-Velasco, M., & Aguilar-Cazares, D. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.578418 · Cited by 306
The role of ASCT2 in cancer: A review
Liu, Y., Zhao, T., Li, Z., Wang, L., Yuan, S., & Sun, L. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.07.007 · Cited by 162
Metadata
- Authors
- Choi, Y.-K., & Park, K.-G.
- Venue
- Biomolecules & Therapeutics
- Published
- 2018-01-01
- Volume
- 26
- Issue
- 1
- Pages
- 19-28
- ISSN
- 1976-9148 (ISSN-L)
- 2005-4483
- OpenAlex
- W2771345740
- Cited by
- 317
- References
- 88
- FWCI
- 7.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.